Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): HPV

This chapter comprehensively explores the role of pharmacists in the prevention and management of human papillomavirus (HPV) from clinical, economic, and humanistic perspectives. It highlights the pharmacist’s multifaceted contributions to vaccination counseling, medication therapy management (MTM), patient education, adherence promotion, and collaborative care. Evidence supports pharmacists’ capacity to improve clinical outcomes by reducing HPV transmission, managing HPV-related complications, and enhancing quality of life (QoL). Economically, pharmacists’ interventions lead to significant cost savings by preventing late-stage HPV-related diseases, minimizing hospitalizations, and promoting the use of cost-effective medications. Humanistically, pharmacists play a critical role in alleviating stigma, addressing psychosocial concerns, and fostering informed health behaviors through patient-centered counseling. The chapter also identifies key facilitators and barriers influencing pharmacists’ engagement in HPV care, including training, regulatory frameworks, time constraints, and societal perceptions. Ultimately, expanding pharmacistled initiatives in HPV care can significantly reduce disease burden and optimize public health outcomes.